RWLK REWALK ROBOTICS LTD

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time.

Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows:

Time8:30 A.M EDT
Toll free (U.S.)(866) 374-5140
International (U.S)(404) 400-0571
Germany8001897777
Israel4044000571
Access Code43100176#
Webcast (live and replay) under the ‘Investors’ section'.

The archived webcast will be available via the following link

or through the 'Investors' section' on .

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit .

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States. 

Investor Contact:

Almog Adar

Director of Finance 

ReWalk Robotics Ltd.

T:

E: 



EN
03/08/2022

Underlying

RWLKREWALK ROBOTICS LTD

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on REWALK ROBOTICS LTD

 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic...

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for  of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for individuals with spinal cord injury Reimbursement coverage is expected to give Lifeward stronger revenue and cash flow dynamics to scale growth MARLBORO...

December 3, 2025 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Ap...

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that it received it...

November 17, 2025 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Lifeward Ltd. Reports Third Quarter 2025 Financial Results Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established  Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27% decrease in quarterly Non-GAAP operating loss Entered into $3.0 million loan agreement with Oramed Ltd. providing additional capital support MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to tr...

November 14, 2025 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward to Report Third Quarter Financial Results on November 14, 202...

Lifeward to Report Third Quarter Financial Results on November 14, 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its third quarter 2025 financial results before the markets open on Friday, November 14, 2025. Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial Officer, will host a conference c...

November 10, 2025 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7...

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that it received its first payment from a commercia...

September 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch